<DOC>
	<DOCNO>NCT01533922</DOCNO>
	<brief_summary>The primary objective trial investigate effect 6 week treatment tiotropium + olodaterol fix dose combination inhalation solution lung hyperinflation exercise tolerance patient COPD</brief_summary>
	<brief_title>Effect Exercise Endurance Lung Hyperinflation Tiotropium + Olodaterol COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : 1 . All patient must sign informed consent consistent ICHGCP guideline prior participation trial , include medication washout restriction . 2 . All patient must diagnosis chronic obstructive pulmonary disease must meet follow spirometric criterion : Patients must relatively stable airway obstruction postbronchodilator FEV1 &lt; 80 % predict normal postbronchodilator FEV1/FVC &lt; 70 % Visit 1 . 3 . Male female patient , 40 75 year age ( inclusive ) day sign informed consent . 4 . Patients must current exsmokers smoke history 10 pack year . Exclusion criterion : 1 . Patients significant disease COPD ; significant disease define disease , opinion investigator , may ( ) put patient risk participation study , ( ii ) influence result study , ( iii ) cause concern regard patient 's ability participate study 2 . Patients clinically relevant abnormal baseline haematology , blood chemistry , urinalysis ; patient SGOT &gt; x2 ULN , SGPT &gt; x2 ULN , bilirubin &gt; x2 ULN creatinine &gt; x2 ULN exclude regardless clinical condition 3 . Patients history asthma . For patient allergic rhinitis atopy , source documentation require verify patient asthma . Patients follow condition : 4 . A diagnosis thyrotoxicosis ( due know class side effect profile ß2agonists ) 5 . A diagnosis paroxysmal tachycardia ( &gt; 100 beat per minute ) ( due know class side effect profile ß2agonists ) 6 . A history myocardial infarction within 1 year screen visit ( Visit 1 ) 7 . Unstable lifethreatening cardiac arrhythmia 8 . Hospitalized heart failure within past year 9 . Known active tuberculosis 10 . A malignancy patient undergone resection , radiation therapy chemotherapy within last five year ( patient treat basal cell carcinoma allow ) 11 . A history lifethreatening pulmonary obstruction 12 . A history cystic fibrosis 13 . Clinically evident bronchiectasis 14 . A history significant alcohol drug abuse 15 . Any contraindication exercise test . 16 . Patients undergone thoracotomy pulmonary resection ( patient history thoracotomy reason evaluate per exclusion criterion No . 1 ) 17 . Patients treat oral ßadrenergics 18 . Patients treat oral corticosteroid medication unstable dose 19 . Patients regularly use daytime oxygen therapy one hour per day investigator 's opinion unable abstain use oxygen therapy clinic visit 20 . Patients complete pulmonary rehabilitation program six week prior screen visit patient currently pulmonary rehabilitation program 21 . Patients limitation exercise performance result factor fatigue exertional dyspnoea , arthritis leg , angina pectoris claudication morbid obesity . 22 . Patients take investigational drug within one month six half life ( whichever great ) prior screen visit 23 . Patients know hypersensitivity ßadrenergics drug , anticholinergic drug , BAC , EDTA component Respimat® inhalation solution delivery system 24 . Pregnant nursing woman 25 . Women childbearing potential use highly effective method birth control .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>